> Quick answer: Gly-His-Lys (GHK) in Neosimply does not have a measured Ki value for TGFBR2, nor is there any published receptor binding data comparing it to GHK-Cu. The competitive mechanism appears largely theoretical based on current literature.
Tripeptide-1, also known as Gly-His-Lys (GHK), is included in the Neosimply formula at 2% in dry capsule form. It’s marketed as a “free peptide receptor competition” agent, targeting TGF-β1 receptors. However, the question remains: does this mechanism hold up to scientific scrutiny? Let’s dive into the available research and see what the data says.
The Mechanism of Tripeptide-1
Tripeptide-1 is part of a family of peptides that can influence various cellular processes, including collagen synthesis and wound healing. In its copper-bound form (GHK-Cu), it has been widely studied for its effects on skin health. However, when it comes to the specific mechanism of receptor competition at TGFBR2, the data is surprisingly sparse.
No Measured Ki Value
None of the 25 book excerpts provide a measured Ki value for Gly-His-Lys (GHK) or its copper complex (GHK-Cu) at the TGF-β type-II receptor (TGFBR2). This means there are no direct binding studies that quantify how strongly these peptides interact with the receptor [1].
Indirect Evidence of Activity
While there is no measured Ki value, some indirect evidence suggests GHK and GHK-Cu can increase biological activity. For example, GHK-Cu has been shown to enhance the effects of endogenous TGF-β1 through mechanisms such as activation of latent TGF-β1 rather than direct competition [2]. This enhancement is often described in terms of “amplifying” or “potentiating” the signaling pathway.
Comparison Between GHK and GHK-Cu
To better understand the differences between GHK and its copper complex, it’s useful to compare their effects directly:
| Property | GHK (Gly-His-Lys) | GHK-Cu |
|————–|———————–|————|
| Collagen Stimulation | No effect observed at 10⁻⁷ M [3] | Dose-dependent rise in collagen synthesis [4] |
| Copper Dependence | Copper is largely obligatory for full activity [5] | Enhanced by copper presence [6] |
Functional Studies
Despite the lack of direct binding data, multiple cell culture studies indicate that GHK and GHK-Cu consistently enhance TGF-β-driven outputs such as collagen secretion. For example, Maquart’s 1988 study found that GHK-Cu evokes a dose-dependent rise in collagen synthesis [7]. However, GHK alone showed no effect at concentrations up to 10⁻⁷ M.
Theoretical vs. Experimental Evidence
The literature is unanimous in describing GHK and its copper complex as TGF-β pathway enhancers rather than competitors. No studies have provided quantitative data on the Ki or IC₅₀ values for these peptides at TGFBR2 [8]. Furthermore, no displacement curves against ¹²⁵I-TGF-β1 or mutagenesis mapping of a putative peptide-binding pocket on TGFBR2 exist [9].
Theoretical Basis
The “competitive” mechanism is largely theoretical and based on the idea that a histidine-containing tripeptide might transiently coordinate receptor residues analogous to the TGF-β1 finger region. However, this analogy remains untested in direct binding assays.
Key Takeaways
- There are no measured Ki values for Gly-His-Lys or GHK-Cu at TGFBR2.
- All functional studies portray these peptides as enhancers of TGF-β signaling pathways.
- The competitive mechanism described is theoretical and lacks empirical support.